Evidence map›Paper›PMID 32958645›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Circulating testican-2 is a podocyte-derived marker of kidney health.

Debby Ngo, Donghai Wen, Yan Gao, Michelle J Keyes, Erika R Drury, Dan H Katz, Mark D Benson, Sumita Sinha, Dongxiao Shen, Laurie A Farrell and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Testican-2 (SPOCK2): A multifunctional matricellular regulator.Matrix biology : journal of the International Society for Matrix Biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Renal Arteriovenous Gradients for Greater Than 10,000 Circulating Proteins.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. suPAR: An Inflammatory Mediator for Kidneys.Kidney diseases (Basel, Switzerland) · 2022
    Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 2 countries.

Debby NgoDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.ORCID 0000-0003-2681-3475
Donghai WenNephrology Division, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0003-2707-036X
Yan GaoJackson Heart Study, Department of Medicine, University of Mississippi, Jackson, MS 39216.
Michelle J KeyesDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.
Erika R DruryDivision of Nephrology, University of Rochester School of Medicine, Rochester, NY 14642.
Dan H KatzDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.ORCID 0000-0001-7237-8502
Mark D BensonDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.ORCID 0000-0001-8977-2389
Sumita SinhaDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.
Dongxiao ShenDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.
Laurie A FarrellDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.ORCID 0000-0002-5717-527X
Bennet D PetersonDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.
David J FriedmanDivision of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA 02215.
Sammy ElmariahCardiology Division, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0002-8013-8733
Bessie A YoungKidney Research Institute, University of Washington, Seattle, WA 98104.
J Gustav SmithDepartment of Cardiology, Clinical Sciences, Lund University and Skåne University Hospital, 221 84 Lund, Sweden.ORCID 0000-0001-6285-9935
Qiong YangDepartment of Biostatistics, Boston University School of Public Health, Boston, MA 02118.ORCID 0000-0002-3658-1375
Ramachandran S VasanDivision of Preventive Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA 02118.ORCID 0000-0001-7357-5970
Martin G LarsonDepartment of Biostatistics, Boston University School of Public Health, Boston, MA 02118.ORCID 0000-0002-9631-1254
Adolfo CorreaJackson Heart Study, Department of Medicine, University of Mississippi, Jackson, MS 39216.
Benjamin D HumphreysDivision of Nephrology, Washington University of St. Louis School of Medicine, St. Louis, MO 63110.ORCID 0000-0002-6420-8703
Thomas J WangDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0003-4063-6508
Martin R PollakDivision of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA 02215; mpollak@bidmc.harvard.edu eprhee@partners.org.
James G WilsonDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.
Robert E GersztenDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.ORCID 0000-0002-6767-7687
Eugene P RheeNephrology Division, Massachusetts General Hospital, Boston, MA 02114; mpollak@bidmc.harvard.edu eprhee@partners.org.ORCID 0000-0002-4804-7583
Beth Israel Deaconess Medical Center · USBoston University · USMassachusetts General Hospital · USJackson Memorial Hospital · USLund University · SEThe University of Texas Southwestern Medical Center · USUniversity of Rochester · USUniversity of Washington · USWashington University in St. Louis · US

Funding

FRAMINGHAM HEART STUDY - YEAR 5 EXAM75N92019D00031 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAMACHANDRAN, VASAN · 2019 to 2024
$29.8M
TRAINING IN CELL STRUCTURE AND FUNCTION IN NEPHROLOGYT32DK007540 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS, SOBERMAN, ROY · 1986 to 2021
$7.2M
Proteomics of Cardiometabolic and Renal Traits in African AmericansR01HL133870 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI ROBERT E GERSZTEN · 2017 to 2026
$6.7M
Proteomic Pathway Discovery in Cardiovascular DiseaseR01HL132320 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GERSZTEN, ROBERT E, RAMACHANDRAN, VASAN S · 2016 to 2019
$3.4M
Metabolomics of Uremic Symptoms in Dialysis PatientsR01NR017399 · NINR · MASSACHUSETTS GENERAL HOSPITAL · PI RHEE, EUGENE P., SHAFI, TARIQ · 2018 to 2023
$2.8M
Metabolomics of CKD and CKD ProgressionU01DK106981 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RHEE, EUGENE P. · 2015 to 2019
$2.2M
The Role of PPM1G in Apolipoprotein E Biology and Atherosclerotic Cardiovascular DiseaseK08HL145095 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BENSON, MARK DANIEL · 2019 to 2023
$836k
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
NHLBI NIH HHS 75N92019D00031NHLBI NIH HHS HHSN268201500001CNHLBI NIH HHS HHSN268201500001INHLBI NIH HHS HHSN268201800010INHLBI NIH HHS HHSN268201800011CNHLBI NIH HHS HHSN268201800011INHLBI NIH HHS HHSN268201800012CNHLBI NIH HHS HHSN268201800012INHLBI NIH HHS HHSN268201800014CNHLBI NIH HHS HHSN268201800014INHLBI NIH HHS HHSN268201800015INHLBI NIH HHS K08 HL145095NHLBI NIH HHS N01 HC025195NHLBI NIH HHS R01 HL132320NHLBI NIH HHS R01 HL133870NIDDK NIH HHS T32 DK007540NIDDK NIH HHS U01 DK106981NIMHD NIH HHS HHSN268201800013ININR NIH HHS R01 NR017399
6 · The paper itself

Abstract

In addition to their fundamental role in clearance, the kidneys release select molecules into the circulation, but whether any of these anabolic functions provides insight on kidney health is unknown. Using aptamer-based proteomics, we characterized arterial (A)-to-renal venous (V) gradients for >1,300 proteins in 22 individuals who underwent invasive sampling. Although most of the proteins that changed significantly decreased from A to V, consistent with renal clearance, several were found to increase, the most significant of which was testican-2. To assess the clinical implications of these physiologic findings, we examined proteomic data in the Jackson Heart Study (JHS), an African-American cohort (

Indexed as

ProteomicsAptamers, PeptideBiomarkersBlack or African AmericanFemaleGlomerular Filtration RateHumansHypertensionKidneyKidney Function TestsKidney GlomerulusMaleMiddle AgedPodocytesProteoglycansAptamers, PeptideBiomarkersProteoglycansSPOCK2 protein, humanchronic kidney diseaseproteomicstestican-2

Identifiers

PMID32958645
PMCPMC7547280
OpenAlexW3087665261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.